3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Active not recruiting
6
Terminated
3
Withdrawn
2
Unknown
2
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Stomach Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Penile Squamous Cell Carcinoma (PSCC)
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Metastatic Urothelial Cancer
1
Melanoma
1
Lymphatic Metastasis
1
Gestational Trophoblastic Neoplasias (GTN)
1
Endometrial Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Advanced Solid Tumor
1
Interventions
Fulvestrant
58
Trastuzumab
49
Capecitabine
48
Letrozole
45
pembrolizumab
41
Carboplatin
41
Paclitaxel
39
Cyclophosphamide
38
ribociclib
37
pertuzumab
36
abemaciclib
36
Blood Specimen Collection
31
Specimen Handling
28
trastuzumab deruxtecan
27
Docetaxel
27
Surveys and Questionnaires
26
Anastrozole
25
exemestane
24
Tamoxifen
24
palbociclib
21
130-nm albumin-bound paclitaxel
21
Magnetic Resonance Spectroscopy
20
Biopsy
19
sacituzumab govitecan
18
eribulin
18
Radiotherapy
18
Gemcitabine
18
olaparib
17
Injections
17
Epirubicin
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Breast Neoplasms
×
avelumab
×
Clear all
NCT04841148
2026-04-09
PALAVY
Abramson Cancer Center at Penn Medicine
Phase 2
Recruiting
96 enrolled
NCT04360941
2026-04-06
PAveMenT
Royal Marsden NHS Foundation Trust
Phase 1
Recruiting
45 enrolled